Found: 26
Select item for more details and to access through your institution.
Metabolic features of myeloma cells in the context of bone microenvironment: Implication for the pathophysiology and clinic of myeloma bone disease.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1015402
- By:
- Publication type:
- Article
PD-L1/PD-1 Axis in Multiple Myeloma Microenvironment and a Possible Link with CD38-Mediated Immune-Suppression.
- Published in:
- Cancers, 2021, v. 13, n. 2, p. 164, doi. 10.3390/cancers13020164
- By:
- Publication type:
- Article
Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3267, doi. 10.3390/cancers12113267
- By:
- Publication type:
- Article
Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering Myeloma.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1332, doi. 10.3390/cancers12051332
- By:
- Publication type:
- Article
Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients.
- Published in:
- Cancers, 2019, v. 11, n. 3, p. 321, doi. 10.3390/cancers11030321
- By:
- Publication type:
- Article
Angiopoietin 1 and integrin beta 1b are vital for zebrafish brain development.
- Published in:
- Frontiers in Cellular Neuroscience, 2024, p. 1, doi. 10.3389/fncel.2023.1289794
- By:
- Publication type:
- Article
P-139: The impact of CD56 expression in smoldering Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S111, doi. 10.1016/S2152-2650(21)02266-7
- By:
- Publication type:
- Article
Bone Marrow DKK-1 Levels Identify Patients With Smoldering Myeloma With Higher Risk of Progression to Active Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e35, doi. 10.1016/j.clml.2017.03.060
- By:
- Publication type:
- Article
Concomitant Primary Hyperparathyroidism in Patients with Multiple Myeloma: A Possible Link?
- Published in:
- Acta Haematologica, 2021, v. 144, n. 3, p. 302, doi. 10.1159/000509768
- By:
- Publication type:
- Article
Role of 1q21 in Multiple Myeloma: From Pathogenesis to Possible Therapeutic Targets.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 6, p. 1360, doi. 10.3390/cells10061360
- By:
- Publication type:
- Article
A Simplified SARS-CoV-2 Pseudovirus Neutralization Assay.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 389, doi. 10.3390/vaccines9040389
- By:
- Publication type:
- Article
Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-00919-w
- By:
- Publication type:
- Article
The Proteasome Inhibitor Bortezomib Maintains Osteocyte Viability in Multiple Myeloma Patients by Reducing Both Apoptosis and Autophagy: A New Function for Proteasome Inhibitors.
- Published in:
- Journal of Bone & Mineral Research, 2016, v. 31, n. 4, p. 815, doi. 10.1002/jbmr.2741
- By:
- Publication type:
- Article
CD14<sup>+</sup>CD16<sup>+</sup> monocytes are involved in daratumumab‐mediated myeloma cells killing and in anti‐CD47 therapeutic strategy.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 3, p. 430, doi. 10.1111/bjh.16548
- By:
- Publication type:
- Article
Bone marrow Dikkopf‐1 levels are a new independent risk factor for progression in patients with smouldering myeloma.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 5, p. 812, doi. 10.1111/bjh.15026
- By:
- Publication type:
- Article
Monoclonal and Bispecific Anti-BCMA Antibodies in Multiple Myeloma.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 9, p. 3022, doi. 10.3390/jcm9093022
- By:
- Publication type:
- Article
Novel Approaches to Improve Myeloma Cell Killing by Monoclonal Antibodies.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 9, p. 2864, doi. 10.3390/jcm9092864
- By:
- Publication type:
- Article
Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin?
- Published in:
- 2017
- By:
- Publication type:
- journal article
PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.613007
- By:
- Publication type:
- Article
The impact of CD56 expression in smoldering myeloma patients on early progression.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 3, p. 587, doi. 10.1002/hon.3104
- By:
- Publication type:
- Article
Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.684561
- By:
- Publication type:
- Article
Neurofibromatosis type I and multiple myeloma coexistence: A possible link?
- Published in:
- Hematology Reports, 2018, v. 10, n. 1, p. 23, doi. 10.4081/hr.2018.7457
- By:
- Publication type:
- Article
Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45350-8
- By:
- Publication type:
- Article
Oncolytic Virotherapy and Microenvironment in Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 5, p. 2259, doi. 10.3390/ijms22052259
- By:
- Publication type:
- Article
Role of Galectins in Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 12, p. 2740, doi. 10.3390/ijms18122740
- By:
- Publication type:
- Article
Molecular Features of the Mesenchymal and Osteoblastic Cells in Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 24, p. 15448, doi. 10.3390/ijms232415448
- By:
- Publication type:
- Article